Aims & Scope
Current Alzheimer Research publishes peer-reviewed frontier review, research, drug clinical trial studies and letter articles on all areas of Alzheimer’s disease. This multidisciplinary journal will help in understanding the neurobiology, genetics, pathogenesis, and treatment strategies of Alzheimer’s disease. The journal publishes objective reviews written by experts and leaders actively engaged in research using cellular, molecular, and animal models. The journal also covers original articles on recent research in fast emerging areas of molecular diagnostics, brain imaging, drug development and discovery, and clinical aspects of Alzheimer’s disease. Manuscripts are encouraged that relate to the synergistic mechanism of Alzheimer's disease with other dementia and neurodegenerative disorders. Book reviews, meeting reports and letters-to-the-editor are also published. The journal is essential reading for researchers, educators and physicians with interest in age-related dementia and Alzheimer’s disease. Current Alzheimer Research provides a comprehensive 'bird's-eye view' of the current state of Alzheimer's research for neuroscientists, clinicians, health science planners, granting, caregivers and families of this devastating disease.
Science Citation Index-Expanded, Journal Citation Reports/Science Edition, InCites, Neuroscience Citation Index, Current Contents® - Life Sciences, Current Contents® - Clinical Medicine, BIOSIS, BIOSIS Previews, BIOSIS Reviews Reports and Meetings, MEDLINE/PubMed/Index Medicus, Scopus, EMBASE, Chemical Abstracts Service/SciFinder, PsycINFO, ProQuest, ChemWeb, Google Scholar, BIOBASE, EMNursing, EMCare, Alzforum, MediaFinder®-Standard Periodical Directory, Genamics JournalSeek, PubsHub, Index Copernicus, J-Gate, CNKI Scholar, Suweco CZ, TOC Premier, EBSCO, British Library, Ulrich's Periodicals Directory and JournalTOCs.
|Frontiers in Clinical Drug Research – Alzheimer Disorders
You can view the contents of this
eBook [here] .
"Current Alzheimer Research is a great source of the most relevant and timely research in the field of AD research."
Rudolph E. Tanzi
Massachusetts General Hospital, and Harvard Medical School, USA
My experience with Bentham Science Publishers’ "Current Alzheimer Research" was positive. While the review process of the manuscript was a bit too long, on the other hand the great contribution given by the Editor in Chief to the interpretation of the data I presented was brilliant. His suggestions have greatly improved the quality of my manuscript and so at the end my experience was very positive.
(Molecular Markers Laboratory, IRCCS Istituto Centro San Giovanni di Dio- Fatebenefratelli, Brescia, Italy.)